ApoB/ApoA1 ratio: what your result means.

Ratio of atherogenic to protective particles; a key cardiovascular risk gauge. ApoB/ApoA1 ratio is measured by blood test as part of the Cardiovascular panel in the HodieLabs Health Blueprint.

Why ApoB/ApoA1 ratio matters

Integrates atherogenic and protective lipoprotein axes into a single number. May outperform LDL-C and HDL-C individually for risk prediction.

Associated risks when out of range: Superior composite predictor of myocardial infarction risk. Captures both atherogenic burden (ApoB) and protective capacity (ApoA1). Elevated ratio signals net atherogenic imbalance.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets ApoB/ApoA1 ratio, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• INTERHEART study (Yusuf et al. The Lancet 2004): across ~30,000 participants in 52 countries, the ApoB/ApoA1 ratio explained roughly half of population-attributable heart attack risk, the strongest single modifiable factor identified, ahead of smoking and hypertension.
• AMORIS study (Walldius et al. The Lancet 2001): the ratio predicted fatal myocardial infarction better than total cholesterol or LDL-C in ~175,000 adults, in both sexes and at all cholesterol levels.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets ApoB/ApoA1 ratio against published clinical authority standards, never arbitrary "optimal" ranges. Measured in ratio:

Band	Range (ratio)
Optimal	<0.60 ratio
Borderline	0.60–0.80 ratio
High	0.81–1.00 ratio
Very high	>1.00 ratio

Clinical interpretation

• Integrates atherogenic and protective lipoprotein axes into a single number.
• May outperform LDL-C and HDL-C individually for risk prediction.
• Useful when LDL-C and ApoB are discordant.

What improves it: the evidence-based levers

• Reduce ApoB via diet, statins, or PCSK9 inhibitors
• Increase ApoA1 via aerobic exercise and weight loss

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How ApoB/ApoA1 ratio testing works at HodieLabs

ApoB/ApoA1 ratio is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Yusuf S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (INTERHEART). Lancet. 2004;364:937–952.
2. Walldius G, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study). Lancet. 2001;358:2026–2033.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.